about
GATA-3 expression identifies a high-risk subset of PTCL, NOS with distinct molecular and clinical features.The role of front-line anthracycline-containing chemotherapy regimens in peripheral T-cell lymphomas.Integrated genomic sequencing reveals mutational landscape of T-cell prolymphocytic leukemiaBone marrow osteoblast damage by chemotherapeutic agents.Whole-genome sequencing identifies recurrent somatic NOTCH2 mutations in splenic marginal zone lymphoma.Conversion of the LIMA1 tumour suppressor into an oncogenic LMO-like protein by API2-MALT1 in MALT lymphoma.Survival in patients with limited-stage peripheral T-cell lymphomasNorth American blastomycosis of the eyelid.Case report: cytogenetic and molecular analysis of proximal interstitial deletion of 4p, review of the literature and comparison with wolf-hirschhorn syndrome.High incidence of Philadelphia chromosome-like acute lymphoblastic leukemia in older adults with B-ALL.Molecular diagnostics of T-cell lymphoproliferative disorders.Diagnosis of splenic B-cell lymphomas in the bone marrow: a review of histopathologic, immunophenotypic, and genetic findings.Acute Myeloid Leukemia Genetics: Risk Stratification and Implications for Therapy.Mature T-cell leukemias: Molecular and Clinical Aspects.Functional proteogenomics reveals biomarkers and therapeutic targets in lymphomas.Comprehensive Assessment and Classification of High-Grade B-cell Lymphomas.A novel recurrent NPM1-TYK2 gene fusion in cutaneous CD30-positive lymphoproliferative disorders.T-cell Receptor Signaling Activates an ITK/NF-κB/GATA-3 axis in T-cell Lymphomas Facilitating Resistance to Chemotherapy.Genomic analyses reveal recurrent mutations in epigenetic modifiers and the JAK-STAT pathway in Sézary syndromeEffects of carnitine and taurine on fatty acid metabolism and lipid accumulation in the liver of cats during weight gain and weight loss.The "Black Turbinate" sign: An early MR imaging finding of nasal mucormycosis.Colony-Stimulating Factor-1 Receptor Is Required for Nurse-like Cell Survival in Chronic Lymphocytic Leukemia.A single center phase II study of ixazomib in patients with relapsed or refractory cutaneous or peripheral T-cell lymphomas.Survival following salvage therapy for primary refractory peripheral T-cell lymphomas (PTCL).Polo-like-kinase 1 (PLK-1) and c-myc inhibition with the dual kinase-bromodomain inhibitor volasertib in aggressive lymphomas.Imatinib Treatment in PDGFRA-Negative Childhood Hypereosinophilic Syndrome.Requisite analytic and diagnostic performance characteristics for the clinical detection of BRAF V600E in hairy cell leukemia: a comparison of 2 allele-specific PCR assays.Evaluation of allele-specific PCR and immunohistochemistry for the detection of BRAF V600E mutations in hairy cell leukemia.Disease Progression in a Patient With Indolent T-Cell Lymphoproliferative Disease of the Gastrointestinal TractMetastatic alveolar rhabdomyosarcoma to the bone marrow mimicking acute leukemiaAggressive Myeloid Sarcoma Causing Recurrent Spinal Cord CompressionOncogenic N-Ras and Tet2 haploinsufficiency collaborate to dysregulate hematopoietic stem and progenitor cellsClinicopathologic characterisation of myeloid neoplasms with concurrent spliceosome mutations and myeloproliferative-neoplasm-associated mutationsColony-Stimulating Factor 1 Receptor (CSF1R) Activates AKT/mTOR Signaling and Promotes T-Cell Lymphoma ViabilityAcute myeloid leukemia with isolated del(5q) is associated with IDH1/IDH2 mutations and better prognosis when compared to acute myeloid leukemia with complex karyotype including del(5q)Molecular Genetics in the Diagnosis and Biology of Lymphoid NeoplasmsWhat is new in mature T-cell leukemias?Impact of Genetics on Mature Lymphoid Leukemias and Lymphomas
P50
Q33585286-3C94C7C0-5C1A-4BFB-81FA-C7A3A959356EQ33702181-1F4C5143-D179-485B-B226-C2E292B1150CQ34106849-B16148C8-375B-4B27-8DBF-78AC83F92B8BQ34170223-BAC89AFE-ED25-418F-BCFF-00F6EB865E7BQ34293927-E55DE388-17D9-417A-BEAB-C777072F2215Q34457270-0EE957E4-715A-4521-9674-5393E8B77591Q35685336-1F93AB4C-365A-42A7-892A-501F43045E53Q37489381-A0283284-60A0-4031-8F69-70558D4040BBQ37696912-54E4C15F-F70E-4E8F-979D-0ECBC1E4C633Q37739018-AF0F84EC-D74B-47F4-8CB3-971F3F4E5570Q38180365-6EC24FED-655D-4A18-8C5D-4284214A7462Q38255491-B048DAE6-3A7C-485C-9D7C-568F1C9AF257Q38594507-EEB163C3-888F-44CB-B4A1-5E067B42C397Q38598546-0C46D106-A690-4ED3-9F33-AB0226E919F2Q38728986-CE6A7014-2003-4E92-8C72-D735EE1DA244Q38759604-411F58A3-0AF1-4782-A89B-C58909BCF36FQ38944677-B4673FEB-EA55-4F5F-A8DA-4218AAE507F9Q40476069-BC165779-2DE7-4EE8-8601-351E7F99EF12Q41077253-DA89FCD5-64A5-4C3A-8B4B-8961F4133584Q44641152-C503A9F4-9C58-4B85-AF70-547266656453Q44952154-3333AD63-7238-4003-9F6E-0F3AC83DE943Q46325508-86E17645-4F73-422F-BF6C-B6846FA6A442Q47902760-D9045DC7-9F16-42DE-8CE9-9E556DE4A6E3Q48197102-56328BE5-7B0E-4E54-B29F-AF51A5F8B8BAQ49421936-FD4EC0B5-9501-4D83-A17E-DECD80AF9E6AQ50996871-E16CB66D-4373-4303-8196-125662BE93D7Q54379161-65604919-4C28-4F59-974C-8709A4BFAB0FQ55069257-59A53F08-0C81-40EB-86BA-B166DF843717Q62092275-FD466167-0495-4454-87E5-9BD81089502EQ85826660-D78FCAF6-E75B-4186-BF99-3E5BEDE67446Q87143354-C04199D9-C7C3-4227-8748-6E482638CD93Q88984217-BAC05628-7A25-42DF-B0E2-AA27F2481FF7Q90688861-67ACFD19-AB75-4F47-9EA2-61C150B9E6D1Q90856144-E41F36F2-62B6-4B19-BBB3-9D9E2B31BF8AQ91106400-FDEA72A2-A7CD-4C80-AB2A-DFAD9835B818Q91669272-90F125B1-78E6-4936-A3A2-FE5634BCD6D1Q92513887-B98AA552-11D7-4334-80F9-62F6B041A981Q92608851-A8B28BF3-DA86-441B-BB31-84B6A847AF05
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Nathanael G. Bailey
@ast
Nathanael G. Bailey
@en
Nathanael G. Bailey
@es
Nathanael G. Bailey
@nl
Nathanael G. Bailey
@sl
type
label
Nathanael G. Bailey
@ast
Nathanael G. Bailey
@en
Nathanael G. Bailey
@es
Nathanael G. Bailey
@nl
Nathanael G. Bailey
@sl
prefLabel
Nathanael G. Bailey
@ast
Nathanael G. Bailey
@en
Nathanael G. Bailey
@es
Nathanael G. Bailey
@nl
Nathanael G. Bailey
@sl
P106
P1153
30067531300
P21
P31
P496
0000-0002-6747-680X